Nuance Communications (NASDAQ:NUAN) Releases FY 2019 Earnings Guidance

Nuance Communications (NASDAQ:NUAN) issued an update on its FY 2019 earnings guidance on Wednesday morning. The company provided earnings per share (EPS) guidance of $1.02-1.10 for the period, compared to the Thomson Reuters consensus estimate of $1.17. The company issued revenue guidance of $1.8-1.83 billion, compared to the consensus revenue estimate of $1.86 billion.Nuance Communications also updated its Q4 2019 guidance to $0.24-0.30 EPS.

NASDAQ NUAN traded up $0.04 during trading on Friday, reaching $16.64. 2,456,048 shares of the company’s stock were exchanged, compared to its average volume of 1,581,180. Nuance Communications has a fifty-two week low of $12.66 and a fifty-two week high of $18.16. The company has a market capitalization of $4.41 billion, a price-to-earnings ratio of 20.54, a PEG ratio of 3.85 and a beta of 0.91. The company has a quick ratio of 1.79, a current ratio of 1.79 and a debt-to-equity ratio of 0.93. The stock has a fifty day moving average price of $16.24.

Nuance Communications (NASDAQ:NUAN) last announced its quarterly earnings results on Wednesday, May 8th. The software maker reported $0.12 earnings per share (EPS) for the quarter, missing the Thomson Reuters’ consensus estimate of $0.25 by ($0.13). The firm had revenue of $451.00 million for the quarter, compared to analyst estimates of $449.90 million. Nuance Communications had a net margin of 3.88% and a return on equity of 14.19%. The firm’s quarterly revenue was down 3.2% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $0.27 earnings per share. As a group, sell-side analysts expect that Nuance Communications will post 0.79 earnings per share for the current fiscal year.

Several equities research analysts have recently issued reports on the company. ValuEngine lowered Nuance Communications from a buy rating to a hold rating in a report on Friday, June 21st. Wedbush reiterated a buy rating and set a $22.00 price target on shares of Nuance Communications in a report on Wednesday, July 24th. Zacks Investment Research lowered Nuance Communications from a buy rating to a hold rating in a report on Thursday, July 25th. Finally, BidaskClub lowered Nuance Communications from a sell rating to a strong sell rating in a report on Monday, June 24th. One research analyst has rated the stock with a sell rating, three have assigned a hold rating and one has issued a buy rating to the stock. The company presently has a consensus rating of Hold and a consensus price target of $19.00.

In other news, Director Mark R. Laret sold 10,000 shares of Nuance Communications stock in a transaction dated Monday, June 10th. The stock was sold at an average price of $17.37, for a total transaction of $173,700.00. Following the completion of the sale, the director now directly owns 79,945 shares in the company, valued at approximately $1,388,644.65. The sale was disclosed in a filing with the SEC, which can be accessed through this link. Also, CEO Mark D. Benjamin sold 45,396 shares of Nuance Communications stock in a transaction dated Tuesday, June 11th. The shares were sold at an average price of $17.40, for a total value of $789,890.40. Following the sale, the chief executive officer now owns 629,430 shares of the company’s stock, valued at $10,952,082. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 95,998 shares of company stock valued at $1,638,290. 0.68% of the stock is owned by corporate insiders.

About Nuance Communications

Nuance Communications, Inc provides voice recognition and natural language understanding solutions worldwide. It operates through five segments: Healthcare, Automotive, Enterprise, Imaging, and Other. The Healthcare segment offers clinical speech and clinical language understanding solutions, such as Dragon Medical, a dictation software that allow physicians to capture and document patient care in real-time; transcription solutions, which enable physicians to streamline clinical documentation with a transcription platforms; clinical document improvement and coding solutions; diagnostic solutions that allow radiologists to document, collaborate, and share medical images and reports; and professional and personal productivity solutions to business users and consumers.

Recommended Story: How to track put option volume

Earnings History and Estimates for Nuance Communications (NASDAQ:NUAN)

Receive News & Ratings for Nuance Communications Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nuance Communications and related companies with's FREE daily email newsletter.